Utrecht Platform for Organoid Technology

Our achievements

UPORT has included more than 3000 patients with cancer and non cancer diseases in the Biobank. UPORT contains organoids from different types of cancer at different stages of the disease. Moreover, UPORT contains body material from different non-cancer diseases.

 

Contact us

Do you have a question for the UPORT team? You can contact the study coordinators using the following contact information.

≥ 3000 patients participate in the UPORT Biobank

 

The UPORT Biobank contains around 3000 specimen

 

In the table below you can find the Uport Cancer Biobank organoid overview cultured from different tissue types:

UPORT has contributed to many research papers:

  • Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response

Read more

  • Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification

Read more

  • Adult mouse and human organoids derived from thyroid follicular cells and modeling of Graves’ hyperthyroidism

Read more

  • Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer

Read more

  • Pancreatic cancer organoids recapitulate disease and allow personalized drug screening

Read more

  • Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy

Read more

  • Mouse and human urothelial cancer organoids: A tool for bladder cancer research

Read more